María Ángeles
Serrano García
Profesora Emérita
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (11)
2024
2020
-
Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 5
2018
-
Chemoresistance and chemosensitization in cholangiocarcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1444-1453
-
Genetic heterogeneity of SLC22 family of transporters in drug disposition
Journal of Personalized Medicine, Vol. 8, Núm. 2
-
Molecular bases of the poor response of liver cancer to chemotherapy
Clinics and Research in Hepatology and Gastroenterology
2017
-
Molecular bases of chemoresistance in cholangiocarcinoma
Current Drug Targets, Vol. 18, Núm. 8, pp. 889-900
2016
-
Protective role of biliverdin against bile acid-induced oxidative stress in liver cells
Free Radical Biology and Medicine, Vol. 97, pp. 466-477
2013
-
Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis
Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 14, pp. 4432-4441
2012
-
Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins
Molecular Pharmaceutics, Vol. 9, Núm. 9, pp. 2565-2576
-
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors
Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704
-
Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy
Pharmacological Research, Vol. 66, Núm. 5, pp. 419-427